Enzalutamide
| Enzalutamide | |
|---|---|
| Term | Enzalutamide |
| Short definition | enzalutamide (EN-zuh-LOO-tuh-mide) A drug used to treat prostate cancer that has spread to other parts of the body and is sensitive to castration (has responded to treatments that lower testosterone levels lower) and prostate cancer, which is resistant to castration (has not responded to treatments that lower testosterone levels). It is also being studied in the treatment of other types of cancer. |
| Type | Cancer terms |
| Specialty | Oncology |
| Language | English |
| Source | NCI |
| Comments | |
enzalutamide - (pronounced) (EN-zuh-LOO-tuh-mide) A drug used to treat prostate cancer that has spread to other parts of the body and is sensitive to castration (has responded to treatments that lower testosterone levels lower) and prostate cancer, which is resistant to castration (has not responded to treatments that lower testosterone levels). It is also being studied in the treatment of other types of cancer. Enzalutamide attaches to proteins called androgen receptors, which are found in some prostate cancer cells. These proteins bind to androgens (male hormones) and can cause cancer cells to grow. Enzalutamide blocks these proteins and can stop cancer cells from growing. It's a type of antiandrogen. Also called Xtandi
External links
- Medical encyclopedia article on Enzalutamide
- Wikipedia's article - Enzalutamide
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski